Antimicrobial Composition Synergy Against Resistant Pathogens

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a growing need for novel anti-microbial agents effective against drug-resistant bacteria and fungi, as existing compounds face issues with resistance, side effects, and limited activity against Gram-negative bacteria, particularly due to the increasing prevalence of resistant strains like Staphylococcus aureus and Pseudomonas aeruginosa.

Innovation Solution

A composition comprising trans-cinnamaldehyde, trans-2-methoxycinnamaldehyde, cinnamyl acetate, linalool, cineole, beta-caryophyllene, and benzyl benzoate, which exhibits synergistic effects, providing broad-spectrum activity against both Gram-positive and Gram-negative bacteria, fungi, and viruses, while minimizing toxicity and resistance induction.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If classical anti-bacterial compounds (penicillin, macrolides, quinolones) are used, then bacterial infections can be treated, but drug resistance develops making them ineffective against resistant strains

Engineering Contradiction:
Improveanti-bacterial efficacyVSAvoidresistance to multiple anti-microbial agents
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent applies composite materials by combining multiple essential oil components (cinnamaldehyde, eugenol, thymol, carvacrol, linalool, menthol, cineole, borneol, alpha-terpineol, beta-caryophyllene) into a synergistic composition. This composite approach creates anti-microbial activity that overcomes bacterial resistance to individual compounds, as the multi-component mixture targets multiple bacterial mechanisms simultaneously, preventing single-point resistance development.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent changes the chemical parameters by using natural essential oil constituents with diverse molecular structures and mechanisms of action, rather than relying on single synthetic anti-bacterial compounds. This parameter diversity allows the composition to remain effective against resistant strains including MRSA and multi-drug resistant Gram-negative bacteria.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If hydrophobic and high molecular weight anti-microbial agents are used against Gram-negative bacteria, then some anti-microbial activity is achieved, but the external membrane wall prevents effective crossing and action

Engineering Contradiction:
Improveanti-microbial activityVSAvoidnatural resistance of Gram-negative bacteria
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies local quality by selecting essential oil components with specific molecular properties optimized for penetrating Gram-negative bacterial membranes. The composition includes compounds with varying hydrophobicity and molecular weights, allowing some components to effectively cross the external membrane while others act on intracellular targets, creating localized effectiveness throughout the bacterial cell.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The multi-component essential oil composition overcomes Gram-negative membrane barriers through synergistic action of components with different penetration capabilities, enabling effective anti-microbial activity against Pseudomonas aeruginosa and other resistant Gram-negative strains.

Inventive Principle:
Principle #40Composite materials

3Reliability

If high concentrations of anti-microbial agents are used to ensure efficacy, then bacterial growth is inhibited, but neurotoxicity and hepatotoxicity occur

Engineering Contradiction:
Improveanti-microbial efficacyVSAvoidneurotoxicity and hepatotoxicity
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent changes the concentration parameter by achieving effective anti-microbial activity at low concentrations through synergistic interactions among multiple essential oil components. The combined action of cinnamaldehyde, eugenol, thymol, and other components creates enhanced efficacy that reduces the required dosage, thereby minimizing neurotoxicity and hepatotoxicity risks associated with high-dose single compounds.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent converts the potential harm of individual essential oil components into benefit through synergistic combination. Components that individually might require high doses (and thus cause toxicity) work together at low concentrations, where their combined anti-microbial effect is enhanced while toxic effects are minimized or eliminated.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

4Device complexity

If single compound anti-microbial agents are used, then the mechanism of action is simple, but resistance develops quickly to that specific mechanism

Engineering Contradiction:
Improvesimplicity of mechanismVSAvoidlong-term effectiveness against resistant strains
Core Design Contradiction:
Device complexityVSReliability

Solution Approach 1:

The patent uses composite materials by combining multiple essential oil components with different mechanisms of action (membrane disruption, protein synthesis inhibition, metabolic interference). This multi-mechanism approach prevents bacteria from developing resistance to a single target, as the composition simultaneously attacks multiple bacterial processes, maintaining long-term effectiveness against resistant strains.

Inventive Principle:
Principle #40Composite materials

Data Source

PatentEP2648704B1Anti-microbial composition
Publication Date: 2019.01.16 SEPTEOS
  • EP2648704B1 patent drawingFigure 1~2
  • EP2648704B1 patent drawingFigure 3~4
  • EP2648704B1 patent drawingFigure 5~6

AI summary

This invention pertains to an anti-microbial, in particular anti-bacterial and/or anti-fungal composition comprising cinnamaldehyde, trans-2-methoxy cinnamaldehyde, cinnamyl acetate and linalool. In particular this composition is intended for preventing and/or treating microbial infection in an animal.